Skip to main content

Chemotherapy-induced Nausea and Vomiting Control

Chemotherapy-induced Nausea and Vomiting Control

Contact

If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is now recruiting. Learn more about enrolling here.

Description

For patients (and parents of patients) that have been diagnosed with, pediatric acute lymphoblastic leukemia (ALL), nausea and vomiting are among the most bothersome symptoms during chemotherapy treatment. The overall goal of this study is to find the best strategies used by parents and patients for managing these symptoms when receiving maintenance therapy.

Eligibility and criteria


IRB Number:
21-018666
Eligible age range:
1 months - 18 years
Clinical trial phase:
N/A
Official title:
Chemotherapy-induced Nausea and Vomiting Control: Understanding Preferences of Pediatric Patients and their Parents

What to expect

This study will enroll parents/guardians of patients that have been diagnosed with pediatric acute lymphoblastic leukemia (ALL) that are 18 years old and younger and patients that have been diagnosed with ALL that are 13-18 years old. Participants will be invited to share their experience with chemotherapy-induced nausea and vomiting (CINV). Interviews will be conducted in person or virtually using a moderator guide that centers around discussion surrounding CINV management.

Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.

Jump back to top